Natacha Ipseiz

1.8k citations
26 papers · 997 indexed · h-index 15
Topics
Mesenchymal stem cell research (7 papers)Immune cells in cancer (7 papers)Peroxisome Proliferator-Activated Receptors (6 papers)

In The Last Decade

Natacha Ipseiz

26 papers receiving 993 citations

Peers

Natacha Ipseiz
Comparison fields: 5 of 95
  • Immunology 459
  • Molecular Biology 431
  • Physiology 133
  • Oncology 132
  • Cancer Research 119
Replace Mariya T. Sweetwyne with:
Mariya T. Sweetwyne United States
Yang Du China
Szandor Simmons Germany
Zhenbiao Wu China
Shunyuan Lu China
Katsuhide Okunishi Japan
Ghada Alsaleh France
Patrizia Rovere–Querini Italy
Irene Krukovets United States
Madalina V. Nastase Germany
Natacha Ipseiz relative to Mariya T. Sweetwyne United States Mariya T. Sweetwyne's profile →
Citations per field
00.5×1.5×2.2×
Mariya T. Sweetwyne · 1×
Citations per year

Countries citing papers authored by Natacha Ipseiz

Since Specialization
Citations

This map shows the geographic impact of Natacha Ipseiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natacha Ipseiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natacha Ipseiz more than expected).

Fields of papers citing papers by Natacha Ipseiz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natacha Ipseiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natacha Ipseiz. The network helps show where Natacha Ipseiz may publish in the future.

Co-authorship network of co-authors of Natacha Ipseiz

This figure shows the co-authorship network connecting the top 25 collaborators of Natacha Ipseiz. A scholar is included among the top collaborators of Natacha Ipseiz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natacha Ipseiz. Natacha Ipseiz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 18
3 12
4 19
5 7
6 11
7 20
8 12
9 37
10 9
11 43
12 5
13 148
14 1
15 7
16 36
17 62
18 89
19 50
20 184

About Natacha Ipseiz

Natacha Ipseiz is a scholar working on Genetics, Immunology and Orthopedics and Sports Medicine, having authored 26 papers that have together received 997 indexed citations. Recurring topics across this work include Mesenchymal stem cell research (7 papers), Immune cells in cancer (7 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). The work is most often cited by research in Immunology (459 citations), Cancer Research (119 citations) and Genetics (78 citations). Natacha Ipseiz has collaborated with scholars based in Germany, United Kingdom and France. Frequent co-authors include Georg Schett, Gerhard Krönke, Stefan Uderhardt, Tobias Rothe, Aline Bözec, Carina Scholtysek, Martin Herrmann, Olga Oskolkova, Wolfgang Bicker and Valery N. Bochkov. Their work appears in journals such as Journal of Clinical Investigation, Nature Medicine and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026